Two Driver Mutations Exist in Osimertinib-Resistant Patient Tumors

    Cancer Discovery
    |February 5, 2022
    PubMed

    Insights

    Single cells develop new genetic changes alongside initial EGFR mutations, leading to treatment resistance. Understanding these additional drivers is key for overcoming drug resistance in cancer therapy.

    Area of Science:

    • Oncology
    • Molecular Biology
    • Genetics

    Background:

    • Epidermal growth factor receptor (EGFR) mutations are common drivers in certain cancers.
    • Acquired resistance to EGFR-targeted therapies remains a significant clinical challenge.
    • Understanding the genetic mechanisms of resistance is crucial for improving patient outcomes.

    Purpose of the Study:

    • To investigate the genetic alterations that arise in single cells during EGFR-targeted therapy resistance.
    • To identify additional driver mutations that cooperate with initial EGFR mutations.

    Main Methods:

    • Single-cell sequencing of resistant cancer cells.
    • Genomic analysis to identify driver alterations.
    • Functional studies to validate the role of identified mutations.

    Main Results:

    • Single cells exhibited diverse genetic profiles beyond the initial EGFR mutation.
    • Specific additional driver alterations were identified that contribute to resistance.
    • These alterations were found to cooperate with EGFR mutations to promote cell survival.

    Conclusions:

    • Acquired resistance to EGFR inhibitors is often driven by the emergence of additional genetic alterations in single cells.
    • Targeting these secondary drivers may offer new therapeutic strategies.
    • Further research into the complex genetic landscape of resistance is warranted.

    Related Concept Videos

    Treatment Resistant Cancers02:56

    Treatment Resistant Cancers

    Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
    3.4K
    Cancer-Critical Genes II: Tumor Suppressor Genes01:05

    Cancer-Critical Genes II: Tumor Suppressor Genes

    Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
    When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
    Such genes that act...
    8.3K
    Loss of Tumor Suppressor Gene Functions01:12

    Loss of Tumor Suppressor Gene Functions

    Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
    When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
    5.2K
    Cancer-Critical Genes I: Proto-oncogenes01:33

    Cancer-Critical Genes I: Proto-oncogenes

    Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
    When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
    Such genes that act...
    9.2K
    Cancers Originate from Somatic Mutations in a Single Cell02:21

    Cancers Originate from Somatic Mutations in a Single Cell

    Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
    13.2K
    The Retinoblastoma Gene01:20

    The Retinoblastoma Gene

    Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
    The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
    4.2K